FDA - Food and Drug Administration
Trump claims unnamed drug can bring people back from death, boasts success of Right To Try Act
"We've taken people that were dead. We had a person given the last rites - gone, the kids are crying, and everything - and started them on this drug. And the person became better," Trump insisted.
FDA launches safety study of abortion pill Mifepristone with White House approval
Trump to expand prescription drug site with 600 cheaper generic medicines in push to lower costs
Cellular Intelligence strikes deal with Novo Nordisk to advance Parkinson’s cell therapy
Biogen shares slide as Medicare restricts cover of Alzheimer's treatments
The coverage decision by US Centers for Medicare and Medicaid Services (CMS), the health agency that runs Medicare, crushes any hopes of the drug Aduhelm gaining traction.
Wait 3 days, then swab throat and nose when using antigen test, Health Ministry says
The Health Ministry published new recommendations on how to use the at-home kits, amid criticism for their lack of accuracy.
Controversial Alzheimer's drug administered for first time in Israel
This marks the first time that the drug has been used outside of the United States.
Israeli firm SpliSense moves to clinical trials for cystic fibrosis treatment
"It will improve patients' lung function, reduce lung inflammation, enable them to breathe better, and go back to normal life."
US FDA clears Pfizer's COVID-19 booster shot for 12- to 15-year-olds
The FDA said it reviewed published data and real-world evidence on the safety of booster doses provided by the Israeli Ministry of Health.
US authorizes German Firm's at-home COVID-19 test
The approval comes at a time when companies such as Walmart Inc, Walgreens Boots Alliance and CVS Health Corp have limited sales of at-home COVID-19 testing kits as demand surged.
Roche's at home covid test kit gets emergency FDA approval
The test, which uses a anterior nasal swab sample, is 'able to produce accurate, reliable and quick results in as few as 20 minutes' for SARS-CoV-2 and all variants of concern.
US FDA authorizes Pfizer/BioNTech booster for 16- and 17-year-olds
All US adults are currently eligible for booster shots of the three authorized COVID-19 vaccines.
US FDA evaluating effectiveness of COVID-19 vaccines against Omicron
BioNTech and Pfizer's established COVID-19 vaccine will likely offer strong protection against any severe disease from the new Omicron virus variant.
Israeli antibody treatment co. acquires four FDA-approved drugs
The combined 2021 annual global revenue from the four products is expected to be around $45 million.
